Menu Search
Equities

Ventas Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VEN:FRA

Ventas Inc

Actions
  • Price (EUR)53.30
  • Today's Change-0.310 / -0.58%
  • Shares traded161.00
  • 1 Year change+12.80%
  • Beta0.8923
Data delayed at least 15 minutes, as of Jun 30 2025 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. It owns or has investments in approximately 1,387 properties. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), freestanding inpatient rehabilitation facilities (IRFs) and other healthcare facilities.

  • Revenue in USD (TTM)5.08bn
  • Net income in USD142.33m
  • Incorporated1987
  • Employees498.00
  • Location
    Ventas Inc300 N Lasalle Street, Suite 1600CHICAGO 60654United StatesUSA
  • Phone+1 (312) 660-3800
  • Fax+1 (302) 655-5049
  • Websitehttps://www.ventasreit.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.